Last Price$137.11.5%
Market Cap$237.5B
4.6%
Industry median - 9.8%
5Y Historical average - 6.3%
(0.4%)
Industry median - (5.6%)
5Y Historical average - 15.4%
134.5%
Industry median - (7.9%)
5Y Historical average - 26.1%
25.5%
Industry median - (13.2%)
5Y Historical average - 13.6%
ABT Growth Rating
ABT Growth rating
6.3
ABT Growth rating performance
ABT Growth Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with ABT Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$237.5B | 6.3 | 5.6% | 4.6% | 7.3% | 29.9% | 134.5% | (33.4%) | 7.1% | 25.5% | |
$145.9B | 7.0 | 9.3% | 17.6% | 12.2% | (17.9%) | 17.8% | 122.5% | 14.5% | 43.2% | |
$144.5B | 6.4 | 8.7% | 10.2% | 8.0% | 7.1% | (5.6%) | 71.8% | 17.7% | 11.2% | |
$121.2B | 3.9 | 1.3% | 2.7% | 3.7% | (34.2%) | (84.4%) | 96.8% | (3.9%) | 10.9% | |
$41.5B | 4.3 | 5.7% | (4.7%) | 7.1% | 33.0% | 202.2% | (65.0%) | (20.3%) | (53.9%) | |
$31.1B | 7.8 | 22.3% | 11.3% | 14.3% | 39.8% | 4.3% | 42.2% | 27.5% | (11.3%) | |
$25.6B | 4.7 | (1.5%) | (0.8%) | 10.0% | N/A | 50.2% | (277.5%) | N/A | N/A | |
$22.9B | 6.3 | 12.6% | (0.2%) | 7.0% | 0.4% | (17.3%) | 138.5% | 17.2% | 26.5% | |
$21.8B | 3.3 | (6.7%) | (23.5%) | 4.3% | (10.0%) | (33.7%) | 92.4% | 0.5% | 0.6% | |
$17.7B | 8.9 | 20.8% | 12.0% | 17.4% | 102.0% | 105.1% | (34.3%) | N/A | 737.0% | |
$12.9B | 4.6 | 10.7% | 3.5% | N/A | 0.2% | (3.6%) | N/A | 0.8% | 2.4% |
FAQ
What is the Abbott Laboratories (ABT) revenue growth?
The Abbott Laboratories (ABT) revenue growth is 4.6%, which is lower than the industry median of 9.8% and the 5-year historical average of 6.3%.
What is the Abbott Laboratories (ABT) operating income growth?
The Abbott Laboratories (ABT) operating income growth is (0.4%), compared to the industry median of (5.6%) and the 5-year historical average of 15.4%.
What is the Abbott Laboratories (ABT) EPS (Earnings Per Share) growth?
The Abbott Laboratories (ABT) EPS growth is 134.5%, compared to the industry median of (7.9%) and the 5-year historical average of 26.1%.
What is the Abbott Laboratories (ABT) Free Cash Flow (FCF) growth?
The Abbott Laboratories (ABT) Free Cash Flow growth is 25.5%, compared to the industry median of (13.2%) and the 5-year historical average of 13.6%.